The information on this website is intended for healthcare professionals only and is provided solely for the purpose of scientific exchange. By accessing this website you accept this legal disclaimer and you expressly confirm your status as a healthcare professional.
This website is not country specific and may therefore contain information that is not applicable to your country. The website is not intended to provide medical advice and/or treatment guidance. Therefore, before prescribing any product, always refer to information approved by regulatory authorities in your country such as the prescribing information and/or the Summary of Product Characteristics. Novo Nordisk accepts no liability for the accuracy, completeness or use of information on this website, and disclaims any liability to update the information contained on this website.
Marianna Fontana is the director of the University College London (UCL) CMR unit at the Royal Free Hospital. She is professor of cardiology and honorary consultant cardiologist at the National Amyloidosis Centre, University College London, where she is deputy head of the Centre and deputy clinical lead. Prof. Fontana obtained her medical degree (MD) and qualifications as a cardiologist at the University of Pisa. She undertook a PhD at UCL which focused on CMR in cardiac amyloidosis. Her main research interests are cardiac imaging, amyloidosis, and heart failure. She is an intermediate British Heart Foundation Fellow and has co-authored 210 peer reviewed publications with more than 12,900 citations.